Cerebral 5-HT2A Receptor and Serotonin Transporter Binding in Humans Are Not Affected by the val66met BDNF Polymorphism Status or Blood BDNF Levels
Open Access
- 25 August 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 30 (11) , e1-e7
Abstract
Recent studies have proposed an interrelation between the brain-derived neurotrophic factor (BDNF) val66met polymorphism and the serotonin system. In this study, we investigated whether the BDNF val66met polymorphism or blood BDNF levels are associated with cerebral 5-hydroxytryptamine 2A (5-HT2A) receptor or serotonin transporter (SERT) binding in healthy subjects. No statistically significant differences in 5-HT2A receptor or SERT binding were found between the val/val and met carriers, nor were blood BDNF values associated with SERT binding or 5-HT2A receptor binding. In conclusion, val66met BDNF polymorphism status is not associated with changes in the serotonergic system. Moreover, BDNF levels in blood do not correlate with either 5-HT2A or SERT binding.Keywords
This publication has 37 references indexed in Scilit:
- Familial Risk for Mood Disorder and the Personality Risk Factor, Neuroticism, Interact in Their Association with Frontolimbic Serotonin 2A Receptor BindingNeuropsychopharmacology, 2009
- BDNF Val66Met is Associated with Introversion and Interacts with 5-HTTLPR to Influence NeuroticismNeuropsychopharmacology, 2009
- Genetic Variation in Brain-Derived Neurotrophic Factor Is Associated with Serotonin Transporter but Not Serotonin-1A Receptor Availability in MenBiological Psychiatry, 2009
- New insights into the role of brain-derived neurotrophic factor in synaptic plasticityMolecular and Cellular Neuroscience, 2009
- The personality trait openness is related to cerebral 5-HTT levelsNeuroImage, 2009
- Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotypeInternational Journal of Neuropsychopharmacology, 2007
- Serotonin transporter function, but not expression, is dependent on brain‐derived neurotrophic factor (BDNF): in vivo studies in BDNF‐deficient miceJournal of Neurochemistry, 2006
- BDNF Is Expressed in Skeletal Muscle Satellite Cells and Inhibits Myogenic DifferentiationJournal of Neuroscience, 2006
- Severe deficits in 5‐HT2A‐mediated neurotransmission in BDNF conditional mutant miceJournal of Neurobiology, 2006
- Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?Journal of Experimental Medicine, 1999